NICHOLAS M. PAPADOPOULOS, Ph.D.; WILLIAM Z. BORER, M.D.; RONALD J. ELIN, M.D., Ph.D.; LOUIS H. DIAMOND, M.D.
Premature coronary heart disease resulting from accelerated atherosclerosis ranks as a major cause of death among uremic patients who are undergoing chronic hemodialysis (1). Increased concentrations of serum triglycerides (2) and low serum concentrations of highdensity (HD) lipoprotein-cholesterol have been reported in patients with end-stage renal disease treated with chronic maintenance hemodialysis (3, 4). The authors of these reports have suggested that the premature cardiovascular morbidity and mortality seen in this group of patients may be due to the decreased serum concentration of HD lipoprotein or an abnormal biochemical composition of the lipoproteins.
We report here the analysis of serum
Learn more about subscription options.
Register Now for a free account.
PAPADOPOULOS NM, BORER WZ, ELIN RJ, DIAMOND LH. An Abnormal Lipoprotein in the Serum of Uremic Patients Maintained on Chronic Hemodialysis. Ann Intern Med. 1980;92:634–635. doi: 10.7326/0003-4819-92-5-634
Download citation file:
Published: Ann Intern Med. 1980;92(5):634-635.
Nephrology, Renal Replacement Therapy.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only